Overcoming the heterogeneity of cancer antigen expression with an mRNA vaccine and precision LNP delivery.

Therapeutic Innovation Australia 2026 Open access

Read full text
Authors: Therapeutic Innovation Australia
DOI: 10.82292/b8dx-kd78
Cited by: 0

Fields of Study & Subjects

Immunotherapy and Immune Responses RNA Interference and Gene Delivery Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
Therapeutic Innovation Australia
Publication date
17 February 2026
Language
EN